Floatz logo

Foscarnet

Cytomegalovirus Infection

City of Hope Medical CenterSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Cytomegalovirus Infection cohort.

Asset / SponsorPhaseRating
Valganciclovir
The Methodist Hospital Research Institute
Phase 3BB
Ganciclovir
City of Hope Medical Center
Phase 3BB
Letermovir
Fernanda P Silveira, MD, MS
Phase 2B
Cmvpp65-A*0201 Peptide Vaccine
City of Hope Medical Center
Phase 2B
Maribavir
Seoul National University Hospital
Phase 2CCC

View all 16 →

Same molecule, other indications

Foscarnet is also rated in:

cytomegalovirus retinitisDormant
BBB
Indicative ·
72 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
Bartter syndrome with hypocalcemiaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →